HUTCHINSON TECHNOLOGY INC Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2009-01: Study NCT01062685; Company role Collaborator; Phase Observational; Status Completed.
- 2008-09: Study NCT00731978; Company role Lead sponsor; Phase Not applicable; Status Completed.
- 2008-07: Study NCT00725972; Company role Collaborator; Phase Not applicable; Status Withdrawn.
- 2005-07: Study NCT00167596; Company role Collaborator; Phase Phase 2, Phase 3; Status Terminated.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2009-01 | NCT01062685 Near Infrared Spectroscopy (St02) | Collaborator Lead: Beth Israel Deaconess Medical Center | Observational | Completed | Septic Shock | 186 | 2010-01 |
| 2008-09 | NCT00731978 NIRF Trial: Near-Infrared Spectroscopy for Intraoperative Restriction of Fluids Trial | Lead sponsor | Not applicable | Completed | Colorectal Surgery | 27 | 2009-10 |
| 2008-07 | NCT00725972 Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures | Collaborator Lead: University of Pittsburgh | Not applicable | Withdrawn | Hemorrhage | 0 | |
| 2005-07 | NCT00167596 Near Infrared Spectroscopy (NIRS) in Severe Sepsis | Collaborator Lead: University of Versailles | Phase 2, Phase 3 | Terminated | Critical Illness; Severe Sepsis | 103 | 2009-12 |